News Focus
News Focus
icon url

MahinAgency

10/29/24 1:03 PM

#205 RE: Sirpeter #157

NASDAQ: $CRDL is advancing CardiolRx for acute myocarditis and recurrent pericarditis, both in Phase II trials. The company raised $13.5 million

Cardiol sets a 12-month price target of $10